Tuberculosis (TB) is a communicable disease and one of the leading causes of death worldwide, ranking above HIV/AIDS. The WHO and CDC recommend screening for active TB in certain high-risk groups to improve early detection of the disease. More specifically, they recommend a diagnostic nucleic acid amplification test for all patients suspected of having pulmonary tuberculosis, and for those already diagnosed with HIV/AIDS.
Due to the growing number of cases and immunosuppressive treatments, non-tuberculous mycobacterial infections are also steadily rising. Species differentiation is also vitally important for finding appropriate antibiotics and treatment.
The MTBC-NTM REAL TIME PCR KIT marks a breakthrough in diagnostics, allowing the simultaneous detection of Mycobacterium tuberculosis, Mycobacterium tuberculosis complex (MTBC), and other non-tuberculous mycobacteria (NTM) species associated with tuberculosis-like pulmonary diseases. Approved for use with human clinical samples such as sputum, bronchial washings and cell cultures, this kit enables primary screening for the early detection of tuberculosis.